Related Experiment Video
Updated: Nov 9, 2025

06:29
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
437
Planned reduction in Fontan fenestration size using the Atrial Flow Regulator
E Oliver Aregullin1, Bennett Samuel1, Joseph Vettukattil1
1Congenital Heart Center, Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.
Cardiology in the Young
|April 12, 2021
Summary
Fontan fenestration aids cardiac output but can lower oxygen saturation. A novel Atrial Flow Regulator device is presented for controlled fenestration size reduction, improving Fontan circulation management.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Medical Device Innovation
Background:
- Fontan fenestration facilitates right-to-left shunting, enhancing cardiac output and systemic oxygen delivery.
- Improving cardiac function and ventricular pressures can paradoxically increase shunting, potentially reducing arterial oxygen saturation.
- Complete closure of the fenestration may compromise Fontan hemodynamics and reduce cardiac output.
Purpose of the Study:
- To introduce and describe the use of the Atrial Flow Regulator for managing Fontan fenestration size.
- To address the lack of dedicated devices for controlled reduction of Fontan fenestration.
- To explore a method for optimizing Fontan circulation through adjustable fenestration.
Main Methods:
- Utilizing the Atrial Flow Regulator device to achieve stepwise reduction in Fontan fenestration size.
- Clinical application and hemodynamic assessment following fenestration size modification.
- Evaluation of the device's efficacy in managing Fontan circulation parameters.
Main Results:
- The Atrial Flow Regulator enables precise and adjustable reduction of Fontan fenestration.
- Controlled fenestration size modification can potentially optimize Fontan hemodynamics.
- The device offers a new approach to managing the balance between shunting and cardiac output in Fontan patients.
Conclusions:
- The Atrial Flow Regulator is a promising device for Fontan fenestration size reduction.
- This innovation may improve the management of Fontan circulation and patient outcomes.
- Further studies are warranted to fully elucidate the long-term benefits and applications of this device.
Related Concept Videos
Aortic Regurgitation III: Medical Management
138
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
138
Mitral Regurgitation III: Medical Management
88
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
88

